Propranolol Hydrochloride
Product manufactured by Breckenridge Pharmaceutical, Inc.
Indications and Purposes
Indications And Usage Hypertension Propranolol Hydrochloride Extended-Release Capsules, Usp, Are Indicated In The Management Of Hypertension. They May Be Used Alone Or Used In Combination With Other Antihypertensive Agents, Particularly A Thiazide Diuretic. Propranolol Hydrochloride Extended-Release Capsules, Usp, Are Not Indicated In The Management Of Hypertensive Emergencies. Angina Pectoris Due To Coronary Atherosclerosis Propranolol Hydrochloride Extended-Release Capsules, Usp, Are Indicated To Decrease Angina Frequency And Increase Exercise Tolerance In Patients With Angina Pectoris. Migraine Propranolol Hydrochloride Extended-Release Capsules, Usp, Are Indicated For The Prophylaxis Of Common Migraine Headache. The Efficacy Of Propranolol In The Treatment Of A Migraine Attack That Has Started Has Not Been Established, And Propranolol Is Not Indicated For Such Use. Hypertrophic Subaortic Stenosis Propranolol Hydrochloride Extended-Release Capsules, Usp, Improve Nyha Functional Class In Symptomatic Patients With Hypertrophic Subaortic Stenosis. |
All Formulated Excipients (9 Total)
Name | Structure | Kind | Function | Status |
---|---|---|---|---|
1. Ethylcelluloses |
|
Unresolved | ||
2. Hypromellose Phthalate |
|
Unresolved | ||
3. Povidones |
|
Unresolved | ||
4. Diethyl Phthalate |
|
Molecular | ||
5. Polyethylene Glycols |
|
Unresolved | ||
6. Titanium Dioxide |
|
Unresolved | DYE-Dye | |
7. Ammonia |
|
Molecular | ||
8. Potassium Hydroxide |
|
Molecular | B&N-Buffer & neutralizing agent , MISC-Miscellaneous | FS-Substances permitted as optional ingredient in a standardized food. |
9. Ferrosoferric Oxide |
|
Molecular |
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Propranolol Hydrochloride |
|
ZINC20240 |